Swarna Bale
University of Michigan
H-index: 17
North America-United States
Top articles of Swarna Bale
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs | Nature communications | Wenxia Wang Swarna Bale Jun Wei Bharath Yalavarthi Dibyendu Bhattacharyya | 2023 |
Molecular Mechanisms Underlying Systemic Sclerosis–Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: an Update | Priyanka Verma Swarna Bale John Varga Swati Bhattacharyya | 2023/12 | |
Extracellular Matrix–Derived Damage-Associated Molecular Patterns: Implications in Systemic Sclerosis and Fibrosis | Swarna Bale Priyanka Verma John Varga Swati Bhattacharyya | 2023/7/14 | |
Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis | JCI insight | Swarna Bale Priyanka Verma Bharath Yalavarthi Scott Arthur Scarneo Philip Hughes | 2023/7/7 |
Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation | Iscience | Seok-Jo Kim Swarna Bale Priyanka Verma Qianqian Wan Feiyang Ma | 2022/7/15 |
PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis | JCI insight | Dan Xu Swati Bhattacharyya Wenxia Wang Igal Ifergan Ming-Yi Alice Chiang Wong | 2022/3/3 |
Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis | JCI Insight | Swati Bhattacharyya Wenxia Wang Swarna Bale Bharath Yalavarthi Priyanka Verma Pei-Suen Tsou | 2022/9/22 |
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs | Nature communications | Wenxia Wang Swarna Bale Jun Wei Bharath Yalavarthi Dibyendu Bhattacharyya | 2022/10/26 |
599 Selective inhibition Of fibro-inflammatory kinase TAK1: A potential therapeutic strategy to ameliorate systemic sclerosis | Journal of Investigative Dermatology | S Bale P Verma B Yalavarthi S Arthur Scarneo TA Haystead | 2022/8/1 |
779 Deficiency of the TLR4 inhibitory homolog RP105 exacerbates fibrosis | Journal of Investigative Dermatology | W Wang S Bale P Verma S Hasan B Yalavarthi | 2022/8/1 |
Natural product topical therapy in mitigating imiquimod-induced psoriasis-like skin inflammation-underscoring the anti-psoriatic potential of Nimbolide | Indian Journal of Pharmacology | Nilesh Barku More Nivya Sharma Gauthami Pulivendala Swarna Bale Chandraiah Godugu | 2021/7/1 |
Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis | Iscience | Bo Shi Wenxia Wang Benjamin Korman Li Kai Qianqian Wang | 2021/1/22 |
Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention | Swarna Bale John Varga Swati Bhattacharyya | 2021 | |
A20 and its repressor DREAM expression govern susceptibility to fibrosis in systemic sclerosis | Journal of investigative dermatology | Bettina Schock H Abdala-Valencia B Jeong S Bale RB Christmann | 2020/7/1 |
Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases | Gauthami Pulivendala Swarna Bale Chandraiah Godugu | 2020/4 | |
Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo | Toxicology and Applied Pharmacology | Gauthami Pulivendala Swarna Bale Chandraiah Godugu | 2020/3/15 |
Protective effects of nanoceria in imiquimod induced psoriasis by inhibiting the inflammatory responses | Nanomedicine | Akshara Domala Swarna Bale Chandraiah Godugu | 2020/1/1 |